Ask AI

ClinicalThought

Share

Program Content

Activities

  • Optimizing BTKi Use Across CLL
    Expert Q&A: Optimizing BTK Inhibitor Use Across the CLL/SLL Treatment Landscape
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 21, 2026

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network (NCCN) in collaboration with Clinical Care Options, LLC dba Decera Clinical Education.

Supporters

Supported by educational grants from AstraZeneca and Lilly.

AstraZeneca

Lilly

Partners

Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner